Podcasts about neurology clinical practice

Dr. Elizabeth Coon talks with Dr. Peter Novak about how central sensitization plays a role in the autonomic symptoms-sings dichotomy and the importance of addressing both conditions for optimal treatment. Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

Dr. Halley Alexander talks with Dr. Serena Yin about the effectiveness of an electronic medical record best practice alert in preventing iatrogenic interventions for patients with a diagnosis of psychogenic nonepileptic seizures. Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

Dr. Halley Alexander talks with Dr. Samuel W. Terman about patients' perceived seizure risk, seizure risk tolerance, and risk counseling techniques.  Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

Dr. Halley Alexander talks with Dr. Coral M. Stredny about the management of pediatric convulsive status epilepticus, focusing on the importance of seizure action plans and adherence to treatment protocols.  Read the related article in Neurology® Clinical Practice.  Disclosures can be found at Neurology.org. 

Dr. Jessica Ailani talks with Dr. Richard B. Lipton about the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice.  Read the related article with Neurology® Clinical Practice. Disclosures can be found at Neurology.org.   

Prof. Jon Stone talks with Dr. Laura Strom and Meagan Watson about changes in total emergency department and inpatient visits and costs before and after referral to a specialized, comprehensive functional seizure treatment clinic. Read the related article with Neurology® Clinical Practice. Disclosures can be found at Neurology.org.   

Dr. Gordon Smith talks with Dr. Jennifer Morganroth about the increase in thymectomy procedures following the MGTX trial, the differences in access to these surgeries among various demographic groups, and the growing role of minimally invasive surgical techniques. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.

Dr. Trey Bateman talks with Dr. Amy Brodtmann about the complexities of diagnosing FTD and related disorders, emphasizing the need to understand frontal network impairments and the importance of behavioral assessments and psychiatric history in clinical practice. Read the related article in Neurology® Clinical Practice. Disclosures can be found at Neurology.org.

Dr. Shuvro Roy talks with Dr. Giovanna S. Manzano about the management of neurosarcoidosis, highlighting the challenges in diagnosis, treatment approaches, and the importance of collaboration among specialists. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.

Dr. Derek Stitt talks with Dr. Miranda M. Wan about improving training and public awareness to optimize palliative care for patients with neurologic conditions. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.

Dr. Alexander Menze talks with Dr. Adrian Budhram about the common challenges faced by neurologists when interpreting cerebrospinal fluid (CSF) results, particularly in cases of traumatic lumbar punctures. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.  

Host Diane C. McLaughlin, DNP, AGACNP-BC, CCRN, FCCM, welcomes Matthew Kirschen, MD, PhD, FAAN, FNCS, to discuss what critical care professionals need to know about determining brain death/death by neurologic criteria (BD/DNC). In October 2023, a revised consensus practice guideline for the determination of brain death in both children and adults was published in Neurology (Greer DM, et al. Neurology. 2023;101;1112-1132). The guideline integrated guidance for adults and children to provide a comprehensive, practical way to evaluate patients with catastrophic brain injuries to determine whether they meet the criteria for brain death. The Society of Critical Care Medicine (SCCM) offers several additional resources to support critical care clinicians' understanding of the updated guidelines, including an article published in the March 2024 issue of Critical Care Medicine addressing what the critical care team needs to know about the guidelines (Kirschen MP, et al. Crit Care Med. 2024;52:376-386). Dr. Kirchen was the lead author of that article and shares key points in this podcast episode. Other resources include: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Practice Guidelines 2024 Critical Care Congress presentation Free AAN evaluation tool that walks clinicians through the process of brain death evaluation. Special article in Neurology: Clinical Practice that provides a detailed narrative about what has changed in the 2023 guidelines compared to prior guidelines. The article also includes tables outlining comparisons, bolding new recommendations, and italicizing age-specific guidance to easily identify the differences between determining brain death in children versus adults.

Dr. Tesha Monteith talks with Dr. Ashish D. Patel about headache referrals and the implementation of a design thinking approach to improve access to headache care. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.  

Dr. Andy Southerland talks with Dr. Scott Friedenberg about the challenges faced by neurologists in balancing financial productivity with optimal patient care Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.

Dr. Neha Dangayach talks with Drs. Yelena Bodien and Brian Edlow about the concept of cognitive motor dissociation (CMD) in neurocritical care, highlighting its implications for patient assessment and treatment. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.

Dr. Shuvro Roy talks with Dr. Marisa Patryce McGinley about outpatient telemedicine utilization for neurologic conditions and identify potential disparities. Read the related article in Neurology: Clinical Practice.  Disclosures can be found at Neurology.org.  

Dr. Vikram Karnik talks with Dr. Kate Wyman-Chick about distinguishing prodromal dementia with Lewy bodies from prodromal Alzheimer disease, the importance of early diagnosis, and the implications for clinical practice. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Dr. Bhooma Aravamuthan about the modern definition of cerebral palsy, the philosophical implications of diagnostic labels, and the need for clarity in clinical practice. Read the related article in Neurology: Clinical Practice.  Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Drs. Michiko K. Bruno and Lawrence Golbe about a practical diagnostic algorithm for atypical parkinsonian disorders, emphasizing the importance of recognizing these conditions in clinical practice. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.  

Dr. Stacey Clardy talks with Dr. Mary Schroth about the revised SMA recommendations, treatment options available, treatment outcomes, and the future of SMA research and care. Read the related article in Neurology: Clinical Practice.  Disclosures can be found at Neurology.org.

Dr. Shuvro Roy talks with Dr. Riley Bove about managing patients with multiple sclerosis as they navigate family planning and pregnancy. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Dr. Jason Margolesky about the frequency of blepharoclonus in Parkinson disease and atypical Parkinsonian disorders to explore whether this clinical phenomenology may be useful in the evaluation and diagnosis of patients with Parkinsonism. Read the related article in Neurology: Clinical Practice.  Disclosures can be found at Neurology.org.

Drs. Divya Singhal and Myriam Abdennadher discuss their paper, "Work, Parenting, and Well-being. An International Survey of Neurologists During the COVID-19 Pandemic" Read the related article in Neurology: Clinical Practice.  Part 1: https://directory.libsyn.com/episode/index/id/29258023

Dr. Jeff Ratliff talks with Drs. Divya Singhal and Myriam Abdennadher about work-life, parenting, and the well-being of neurologists during the COVID-19 pandemic. Read the related article in Neurology: Clinical Practice. Disclosures can be found at Neurology.org.  

Dr. Gordon Smith talks with Laynie Dratch about integrating genetic testing into patient care for persons with Amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) spectrum disorders. Read the related article in Neurology: Clinical Practice.  Disclosures can be found at Neurology.org 

Dr. Stacey Clardy talks with Drs. Brian Stamm and Behnam Sabayan about the spectrum of clinical presentations, neuroimaging patterns, and the predictors of radiographic and clinical outcomes from diffusion-restricted splenial lesions. Read the related article in Neurology: Clinical Practice.  Visit NPub.org/Podcast for associated article links. Disclosures can be found at Neurology.org   

In this week's episode of the Neurophilia Podcast, we discussed the relationship between Neurology and Palliative Medicine, the need for empathy and vulnerability in patient conversations, the emerging field of Neuropalliative Medicine, how to celebrate the small victories in medicine, and even Dua Lipa! In this episode, we are joined by Dr. Kathleen Neuendorf and Dr. Renato Samala.Dr. Kathleen Neuendorf, MD has been a palliative medicine physician, working primarily as a consultant in the hospital, since 2010. She was drawn to the field because it brought an honesty and clarity that people seemed to need but weren't always getting. Dr. Neuendorf is known both locally and nationally for her work in relationship-centered communication and leadership. Outside of work, she is a proud mom of 3, enjoys spending time with her husband and taking walks in the Metroparks.Dr. Renato V. Samala, MD is a staff physician in the Department of Palliative and Supportive Care at the Taussig Cancer Center, and an Associate Professor of Medicine at Cleveland Clinic Lerner College of Medicine. After graduating from the University of the Philippines College of Medicine, he completed a residency in internal medicine at UPMC McKeesport, and fellowships in Geriatrics and Hospice and Palliative Medicine at Cleveland Clinic. Dr. Samala is a fellow of the American College of Physicians and the American Academy of Hospice and Palliative Medicine. He has written numerous articles published in peer-reviewed journals and textbooks, and has presented at local, national and international conferences.References:Boersma, I., Miyasaki, J., Kutner, J., & Kluger, B. (2014). Palliative care and neurology: Time for a paradigm shift. Neurology, 83(6), 561–567. https://doi.org/10.1212/wnl.0000000000000674 Brizzi, K., & Creutzfeldt, C. (2018). Neuropalliative care: A practical guide for the neurologist. Seminars in Neurology, 38(05), 569–575. https://doi.org/10.1055/s-0038-1668074 Creutzfeldt, C. J., Robinson, M. T., & Holloway, R. G. (2016). Neurologists as primary palliative care providers. Neurology: Clinical Practice, 6(1), 40–48. https://doi.org/10.1212/cpj.0000000000000213 Silveira, M. R., & Forte, D. N. (2022). Palliative care and neurology: A path to neuropalliativism. Arquivos de Neuro-Psiquiatria, 80(5 suppl 1), 328–335. https://doi.org/10.1590/0004-282x-anp-2022-s119 Taylor, L. P., Besbris, J. M., Graf, W. D., Rubin, M. A., Cruz-Flores, S., & Epstein, L. G. (2022). Clinical guidance in neuropalliative care. Neurology, 98(10), 409–416. https://doi.org/10.1212/wnl.0000000000200063 Zehm, A., Hazeltine, A. M., Greer, J. A., Traeger, L., Nelson-Lowe, M., Brizzi, K., & Jacobsen, J. (2019). Neurology clinicians' views on Palliative Care Communication. Neurology: Clinical Practice, 10(6), 527–534. https://doi.org/10.1212/cpj.0000000000000794 Support the show

Dr. Jeff Ratliff talks with Dr. Vikas Kotagal about how neighborhood socioeconomic factors vary among individuals with different types of clinical movement disorders.  Read the related article in Neurology®: Clinical Practice.

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens" Guest: Selim Benbadis, MD It may be challenging for a family member to take a video on their cell phone while a patient is having a seizure. However, they have been deemed useful in helping physicians establish a history of seizures in epileptic patients. So should clinicians consider this as a reimbursable diagnostic tool? Joined by the physician who posed this question in a recent article for the journal Neurology Clinical Practice, Dr. Andrew Wilner speaks with Dr. Selim Benbadis, Professor of Neurology and the Director of the Comprehensive Epilepsy Program at the University of South Florida.

Dr. Halley Alexander talks with Dr. Wyatt Bensken about the difference in antiseizure medications between racial and ethnic groups among people with epilepsy. Read the related article in Neurology Clinical Practice. 

Stroke research is important, and there's not enough of it. Finding funding for small and medium sized projects is hard and getting wider awareness of them is even harder. Collavidence seeks to change that. It's a Kickstarter-like platform for medical research, with a focus on stroke. Research teams Post research projects they are developing, and the public can choose to back them. They also participate in working groups with other experts to further refine the projects as the y pursue results. Collavidence Chief Knowledge Office Dr. Aravind Ganesh joins us in this episode to talk about the platform and how democratizing the research funding process can help us all. If you don't see the audio player below, visit the original post here, or look for the Strokecast in you podcast app.   Click here for a machine-generated transcript Who is Dr. Aravind Ganesh? Dr. Aravind Ganesh Dr. Aravind Ganesh is a Vascular and Cognitive Neurologist. He completed his MD degree at the University of Calgary, followed by a DPhil in Clinical Neurosciences at the University of Oxford's Centre for Prevention of Stroke and Dementia as a Rhodes scholar. He earned an Associate Fellowship from the United Kingdom's Higher Education Academy through his teaching contributions at St John's College (Oxford). He completed his neurology residency in Calgary, followed by a combined fellowship in stroke and cognitive neurology, funded by Alberta Innovates and the Canadian Institutes of Health Research. Dr. Ganesh is a Fellow of the Canadian Stroke Consortium, and is actively involved in the development of best-practice guidelines for stroke and dementia care. His clinical research is focused on the natural history, prevention, and treatment of stroke and cognitive impairment. He is passionate about medical education, and serves on the editorial boards of Neurology, Neurology: Clinical Practice, and Stroke. Should you back projects on Collavidence? Maybe. If you feel the project has value (or could have value), if it sounds like something you would like to support, if the team behind it seem credible, and if you can afford it, go for it! Contributions don't have to be large to be meaningful. Be aware that it's always possible a project won't work out. There are lots of things that can go wrong, just like on other crowd funding platforms like Kickstarter and Go Fund Me. Exercise caution, like you do with other financial concerns. If you want to have a concrete, direct impact on the research projects that can make life better for the stroke community, though, this might be a great way to do it. Survey Do you have thoughts about the Strokecast as a show? I want to hear about it. Please complete the listener survey at http://Strokecast.com/survey by March 31, 2023 to share your insight. I'd realy appreciate it. Hack of the Week This week's hack is more for researchers. That's to communicate with the community. Often researchers may pursue projects to address what they see as problems in the stroke field, and that's great. It's also important, though, to listen to the people they want to help. Does a research project address a problem member of the survivor community actually care about solving? A recurring theme from disability advocates is, "Nothing about us without us." That means before folks try to solve things for people with disabilities, they ought to actually communicate with people with disabilities. Don't try to solve a problem we don't have. And don't assume that solution created by just a group of abled folks will work or appeal to disabled folks. Get the input of people with disabilities, and involve us in the process. Hire disabled consultants and architects on projects benefiting the disabled. And keep in mind that accessible design is good design. Nothing about us without us. Links Where do we go from here? Check out some of the projects on Collavidence.com Share this episode with someone you know with this link: http://Strokecast.com/CrowdFundingResearch Complete the Strokecast listener survey at http://Strokecast.com/survey Don't get best…get better More thoughts from Dr. Aravind Ganesh How can we generate more funding for stroke research and open up research to the broader stroke community around the world? Collavidence may have the answer. We talk about it with Chief Knowledge Officer Dr. Aravind Ganesh in this episode. How can we generate more funding for stroke research and open up research to the broader stroke community around the world? Collavidence may have the answer. We talk about it with Chief Knowledge Officer Dr. Aravind Ganesh in this episode. How can we generate more funding for stroke research and open up research to the broader stroke community around the world? Collavidence may have the answer. We talk about it with Chief Knowledge Officer Dr. Aravind Ganesh in this episode. How can we generate more funding for stroke research and open up research to the broader stroke community around the world? Collavidence may have the answer. We talk about it with Chief Knowledge Officer Dr. Aravind Ganesh in this episode. How can we generate more funding for stroke research and open up research to the broader stroke community around the world? Collavidence may have the answer. We talk about it with Chief Knowledge Officer Dr. Aravind Ganesh in this episode. How can we generate more funding for stroke research and open up research to the broader stroke community around the world? Collavidence may have the answer. We talk about it with Chief Knowledge Officer Dr. Aravind Ganesh in this episode. How can we generate more funding for stroke research and open up research to the broader stroke community around the world? Collavidence may have the answer. We talk about it with Chief Knowledge Officer Dr. Aravind Ganesh in this episode. How can we generate more funding for stroke research and open up research to the broader stroke community around the world? Collavidence may have the answer. We talk about it with Chief Knowledge Officer Dr. Aravind Ganesh in this episode. How can we generate more funding for stroke research and open up research to the broader stroke community around the world? Collavidence may have the answer. We talk about it with Chief Knowledge Officer Dr. Aravind Ganesh in this episode.

Dr. Justin Abbatemarco talks with Dr. Gregg Day from the Mayo Clinic in Jacksonville Florida, about patients with rapidly progressive dementia due to Creutzfeldt-Jakob disease versus other causes. Read the full article in Neurology: Clinical Practice. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Jeff Ratliff talks with Dr. Sana Aslam about her team's paper on the clinicopathologic correlations of jaw tremor in a longitudinal aging study. Read the full article in Neurology: Clinical Practice. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Dr. Stacey Clardy talks with Dr. Micaela Hernández about transient global amnesia and the prevalence and risk factors of relapse. Read the full article in Neurology: Clinical Practice. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.

Luca Bartolini, MD, pediatric epileptologist, assistant professor and director of the Pediatric Epilepsy Program at Hasbro Children's Hospital talks about his journey to becoming editor-in-chief of Neurology: Clinical Practice.

Dr. Justin Abbatemarco talks with Dr. Daniel Hartung about the impact of Medicare Part D plan disease-modifying therapy restrictiveness upon adherence and outcomes among patients with multiple sclerosis. Read the full article in Neurology: Clinical Practice.

Someone who has persistent seizures that last more than 24 hours, despite treatment, is in super refractory status epilepticus, or SRSE. The condition is rare, but often results in death or disability.Bringing someone out of SRSE usually involves treatment with anti-seizure medications and anesthetics, but other therapies are beginning to gain attention. One of those therapies is the ketogenic diet. This high-fat diet has been used to treat some cases of epilepsy for more than 100 years.A recent paper in Neurology Clinical Practice offers practical considerations for the use of the ketogenic diet in patients with super-refractory status epilepticus. ILAE spoke with two of the paper's authors – dietitian Neha Kaul and epileptologist Joshua Laing.For guidance on providing the ketogenic diet, contact Neha Kaul.Read the paper: Practical Considerations for Ketogenic Diet in Adults With Super-Refractory Status Epilepticus | Neurology Clinical Practice More about the ketogenic diet as epilepsy treatment (ILAE Epigraph article).Sharp Waves content is meant for informational purposes only and not as medical or clinical advice. The International League Against Epilepsy is the world's preeminent association of health professionals and scientists, working toward a world where no person's life is limited by epilepsy. Visit us on Facebook, Twitter, and Instagram. Support the showSharp Waves episodes are meant for informational purposes only, and not as clinical or medical advice.The International League Against Epilepsy is the world's preeminent association of health professionals and scientists, working toward a world where no person's life is limited by epilepsy. Visit us on Facebook, Twitter, and Instagram.

Dr. Rae Bacharach discusses an article from Neurology: Clinical Practice, "Pregnancy-related and Perinatal Outcomes in Women with MS A Nationwide Danish Cross-sectional Study". Show references: https://cp.neurology.org/content/early/2021/02/03/CPJ.0000000000001035

In the first segment, Dr. David Lapides talks with Dr. April Zehm about her Neurology: Clinical Practice paper regarding Framing Discussions on Palliative Care in Neurology. In the second part of the podcast, you’ll hear Dr. Lapides’ interview with Dr. David Perez on Diagnosing Functional Neurologic Disorders.  

In the first segment, Dr. Jason Crowell talks with Eric Pachman about his report on copaxone and drug pricing. Next, Dr. Jeffrey Ratliff talks with Dr. Yi Li about her Neurology: Clinical Practice paper discussing ultrasound-guided lumbar puncture.  Disclosures can be found at Neurology.org. No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.

In the first segment, Dr. Dan Ackerman and Dr. Andrew Southerland finish their discussion on managing ischemic stroke, in the 5th of a 5-part series. Next up, Dr. Stacey Clardy talks with Dr. Luise Appeltshauser about her paper discussing paranodal antibodies in acute autoimmune neuropathy. Read Dr. Appelshauser's paper in Neurology: Neuroimmunology & Neuroinflammation: https://nn.neurology.org/content/7/5/e817.  Disclosures can be found at Neurology.org. No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.

In the first part of the podcast, Dr. Jeffrey Ratliff and Dr. Jason Crowell continue their discussion on movement disorder emergencies in the 2nd part of a 2-part dialogue. In the second segment, Dr. Stacey Clardy talks with Dr. Holly Hinson about her Neurology: Clinical Practice editorial on patient and public involvement in clinical trials from the June 2020 issue. Disclosures can be found at Neurology.org. No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.

In the first segment, Dr. Jason Crowell talks with Dr. Daniel Claassen about his Neurology: Genetics paper on genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease. In the second part of the podcast, Dr. Jeffrey Ratliff focuses his discussion with Dr. Roseanne Dobkin on telephone-based CBT for depression in patients with Parkinson disease. Disclosures can be found at Neurology.org. No CME this week: Interviews based on articles from Neurology: Clinical Practice®, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.

MINUTAGEM [02:01] Salves! [03:34] Apresentação Inicial do Caso Clínico [04:35] Diferenciais de perda do nível de consciência [16:50] Anamnese (revisão de prontuário) [19:14] Exame físico [21:30] Diferenciação da sincope por mecanismos [34:28] Representação do problema [38:13] Quais exames pedir? [40:33] Resultados de exames [43:00] Discussão dos exames e hipóteses iniciais para o caso [49:13] Resultado de novos exames [56:30] Fechamento do caso [1:00:00] Desafio da semana Um caso clínico desafiador de síncope! Fred, Pedro e Rapha discutem esse caso apresentado pelo João. Como diferenciar síncope de convulsão? Quais características sugerem uma síncope de causa cardíaca? Tentamos responder essas e outras perguntas nesse episódio. Ficou com alguma dúvida, quer apontar algum erro ou enviar sugestões? Entra em contato com a gente no Instagram @tadeclinicagem ou no e-mail tadeclinicagem@gmail.com! REFERÊNCIAS: JURASCHEK, Stephen P. et al. Association of history of dizziness and long-term adverse outcomes with early vs later orthostatic hypotension assessment times in middle-aged adults. JAMA internal medicine, v. 177, n. 9, p. 1316-1323, 2017. BRIGNOLE, Michele et al. 2018 ESC Guidelines for the diagnosis and management of syncope. European heart journal, v. 39, n. 21, p. 1883-1948, 2018 Shmuely, Sharon, et al. "Differentiating motor phenomena in tilt-induced syncope and convulsive seizures." Neurology 90.15 (2018): e1339-e1346. Fisher, Robert S. "Serum prolactin in seizure diagnosis: Glass half-full or half-empty?." (2016): 100-101. Abubakr, Abuhuziefa, and Ilse Wambacq. "Diagnostic value of serum prolactin levels in PNES in the epilepsy monitoring unit." Neurology: Clinical Practice 6.2 (2016): 116-119. Albassam, Omar T., et al. "Did this patient have cardiac syncope?: the rational clinical examination systematic review." Jama 321.24 (2019): 2448-2457.

Estreando um novo segmento do nosso podcast, o TdC Lab! Rapha, João, Fred e Pedro discutem sobre Líquor: o que pedir, como interpretá-lo e quais são as pegadinhas que precisamos ficar atentos! Referências: 1- Hasbun R. Cerebrospinal fluid in central nervous system infections. In: Infections of the Central Nervous System, 4th edition, Scheld WM, Whitley RJ, Marra CM (Eds), Lippincott Williams, 2014. p.4. 2- Kimberly Johson Daniel Sexton. Cerebrospinal fluid: Physiology and utility of an examination in disease states UPTODATE 12/2019  3- Nilam J Soni et al. Ultrassound Guidance for Lumbar Puncture. Neurology Clinical Practice 2016 4- Kimberly Johnson, Daniel Sexton Lumbar Puncture: Technique, indications, contraindications, and complications in adults Uptodate 12/2019. 5- Basmaci, Romain, et al. Enteroviral meningitis does not exclude concurrent bacterial meningitis. Journal of clinical microbiology 49.9 (2011): 3442-3443. 6- Bailey, Elizabeth M., Philip Domenico, and Burke A. Cunha. Bacterial or viral meningitis? Measuring lactate in CSF can help you know quickly. Postgraduate medicine 88.5 (1990): 217-223. 7- Huy, Nguyen T., et al. Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis. Critical care 14.6 (2010): R240. 8- Posner, Jerome B., and Fred Plum. Independence of blood and cerebrospinal fluid lactate. Archives of neurology 16.5 (1967): 492-496.

Dr. Christopher Tarolli provides the main take-home points from his talk on symptom burden among individuals with Parkinson disease, from his Neurology: Clinical Practice paper. 

In the first segment, Dr. David Lapides talks with Dr. Allan Ropper about NEJM paper on neurosyphilis, which you can read here: https://www.nejm.org/doi/full/10.1056/NEJMx190030. In the second segment, Dr. Jeffrey Ratliff talks with Dr. Christopher Tarolli about his Neurology: Clinical Practice paper on symptom burden among individuals with Parkinson disease. In the second part of the podcast.

In the first segment, Dr. Alex Menze talks with Dr. Jonathan Newmark about his Neurology: Clinical Practice paper that provides an update on therapy for acute nerve agent poisoning. In the second part of the podcast, Dr. Andrew Schomer focuses his discussion with Dr. Jan Claassen on detection of brain activation in unresponsive patients with acute brain injury. Read the full NEJM article here: https://www.nejm.org/doi/full/10.1056/NEJMoa1812757.    Information on managing nerve agent attack can be found here: https://ccc.apgea.army.mil/. Disclosures can be found at Neurology.org. No CME this week: Interviews based on articles from Neurology® Clinical Practice, Neurology® Genetics, and Neurology® Neuroimmunology & Neuroinflammation are excluded from the CME program.

Dr. Jason Crowell highlights a commentary in Neurology: Clinical Practice on the imposter phenomenon and advancing women in neurology practice. You can read the commentary here: https://cp.neurology.org/content/9/2/155. 

Dr. Barbara Weissman discusses the main points from her Neurology: Clinical Practice paper on recommendations for neurologists on the CDC’s Guideline on Pediatric Mild Traumatic Brain Injury. 

In the first segment, Dr. Kristen Heinan talks with Dr. Barbara Weissman about her Neurology: Clinical Practice paper on recommendations for neurologists on the CDC’s Guideline on Pediatric Mild Traumatic Brain Injury. In the second part of the podcast, Dr. Will Rondeau focuses his discussion with Dr. Geoffrey Donnan on his NEJM paper on thrombolysis guided by perfusion Imaging up to 9 hours after onset of stroke. You can read the paper here: https://www.nejm.org/doi/pdf/10.1056/NEJMoa1813046.  

This month’s Delayed Recall highlights episodes on developments and scandals related to genetic testing and technology in neurology. Dr. Jason Crowell and Dr. Josephine Johnston of the Hastings Center start the show discussing the ethical and philosophical implications of gene editing., which first aired on December 18th, 2018. The next segment, also from December 18th, has Dr. Stacey Clardy and Dr. Stefan Pulst focusing on the scientific and societal impact of the recent first reported gene editing using the CRISPR technology. Following this segment is one from December 3rd and finds Dr. Jeff Waugh talking with Dr. Saadet Andrews about her paper on the genetic landscape of pediatric movement disorders and management implications. This episode continues with an interview on a Neurology: Genetics on the long journey to diagnosis for patients with mitochondrial disease between Dr. Jason Crowell and Drs. John L.P. Thompson and Michio Hirano from April 3rd, 2018. The episode wraps up with a talk between Dr. Jeffrey Ratliff and Dr. Thomas Bird from March 20th, 2018, on Dr. Bird’s Neurology: Clinical Practice paper on the benefits and limitations of exome sequencing to identify hereditary ataxias.

In the first segment, Dr. Gregory Day talks with Dr. Brigid Waldron-Perrine about her Neurology: Clinical Practice paper addressing the Montreal Cognitive Assessment as a screening tool. In the second part of the podcast, Dr. Jeffrey Burns focuses his interview with Dr. Mathias Jucker on how serum neurofilament dynamics predict neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. The article can be found in Nature: https://www.nature.com/articles/s41591-018-0304-3.

In the first segment, Dr. James Grogan talks with Dr. David Llewellyn about his Neurology: Clinical Practice paper on predictors of dementia misclassification when using brief cognitive assessments. In the second part of the podcast, Dr. Jason Crowell focuses his interview with Dr. Rob M.A. de Bie on a randomized delayed-start trial of Levodopa in Parkinson’s Disease, published in the New England Journal of Medicine. The article can be found here: https://www.nejm.org/doi/full/10.1056/NEJMoa1809983.

This special Delayed Recall episode is the third installment of our new Practice Current segment. In this episode, Dr. Luca Bartolini speaks with epilepsy experts Dr. Cynthia Harden and Dr. Torbjörn Tomson. They discuss the results of a recent Practice Current (a section of Neurology® Clinical Practice) survey regarding epilepsy treatment and management during pregnancy, and share their thoughts regarding best practices. This is the first appearance of this interview in the podcast.

1. Featured Article: Molecular Genetic Testing for Hereditary Ataxia – What Every Neurologist Should Know2. What’s Trending: Recent changes to Maintenance of Certification Requirements This Neurology® Podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the March 20, 2018, print issue of Neurology. In the first segment, Dr. Jeff Ratliff talks with Dr. Thomas Bird about his Neurology: Clinical Practice paper on the benefits and limitations of exome sequencing to identify hereditary ataxias. For the “What’s Trending” segment, Dr. Stacey Clardy with Dr. Laurie Gutmann about recent updates to the Maintenance of Certification requirements and tips to ease the process for neurologists.DISCLOSURES: Dr. Bird serves on the editorial board for GeneReviews.org; holds patents for genetic testing technology for CMT1C and SCA14; and has received research support from the Department of Veterans' Affairs (Merit Research Grant, PI, 2009-2017). Dr. Gutmann serves on the editorial board for Up-to-Date Online (Hypokalemic and Hyperkalemic Periodic Paralysis); and has recieved research support from Alexion Pharmaceuticals, Inc. and the NIH (U01 NS069498-01 A1, 3P50NS044283-07S1, U01 NS026835-01A1, U01 NS058728-01, and U01 NS077179-01). Dr. Ratliff has received a speaker honorarium from Haverford College. Dr. Clardy has received research support from Western Institute for Biomedical Research (WIBR).

1. Featured Article: Medical Retirement from Sport after Concussions: a practical guide for a difficult discussion2. What’s Trending: CGRP drugs and treatment of migraineThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the February 13, 2018 issue of Neurology. In the first segment, Dr. Jason Crowell talks with Dr. James Noble about his Neurology® Clinical Practice paper on athletes who retire from sport following concussion. In the second part of the podcast, Dr. Tesha Monteith focuses her interview with Dr. Peter Goadsby on CGRP and migraine. DISCLOSURES: Dr. Crowell reports no disclosures. Dr. Noble received travel honoraria for the Big 10/Ivy League concussion summit; has a pending patent for a real-time concussion diagnostic tool; has consulted with Prophase, LLC; has received research support from NIH (U54 NS081765, R01 NS067443, R01AG054536, T35 AG044303); and holds stock options in BATS-TOI. Dr. Goadsby has consulted for Akita, Allergan, Amgen, Autonomic Technologies Inc, Avanir, Cipla, Dr Reddy's Laboratories, Eli-Lilly, Electrocore, eNeura, Pfizer, Scion, Teva, and Trigemina; serves on editorial boards for NEJM Journal Watch, and Neurology Up-to-Date; receives publishing royalties for Mechanism and Management of Headache (Elsevier 2005); holds stock options in Trigemina Inc.; and receives research support from Amgen, and Eli-Lilly. Dr. Monteith serves as an editorial advisory board member for Neurology Now and receives research support from the NIH.

Show description/summary:1) Persistent focal enhancement of the cisternal segment of oculomotor nerve in ophthalmoplegic migraine (Neurology® Clinical Practice)2) What’s Trending: Tenecteplase for acute ischemic strokeThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the October 24, 2017 issue of Neurology. In the first segment, Dr. Heather Harle talks with Dr. Ihtesham Qureshi about his Neurology® Clinical Practice paper on ophthalmoplegic migraine. In the second part of the podcast, Dr. Justin Sattin focuses his interview with Dr. Nicola Logalio on using tenecteplase for acute ischemic stroke. Disclosures can be found at Neurology.org.DISCLOSURES: All participants report no disclosures.

This special Delayed Recall episode is the second installment of our new Practice Current segment. In this episode, Dr. Luca Bartolini speaks with neuromyelitis optica (NMO) experts Dr. Tarso Adoni and Dr. Michael Levy. They discuss the results of a recent Practice Current (a section of Neurology® Clinical Practice) survey regarding NMO treatment, and share their thoughts on best practices. This is the first appearance of this interview in the podcast.

Show description/summary:1) Neurology® Clinical Practice: Barriers and Facilitators to ER Physician Use of the Test and Treatment for BPPV2) What’s Trending: New crowd-funding research initiative from ABFIn the first segment, Dr. Jim Siegler talks with Dr. Kevin Kerber and Dr. William Meurer about their Neurology® Clinical Practice article on ER physician use of the test and treatment for benign paroxysmal positional vertigo. In the second part of the podcast, Dr. Andy Southerland focuses his interview with Dr. Robert Griggs and Jane Ransom on the new crowd-funding research initiative from the American Brain Foundation. Disclosures can be found at Neurology.org.DISCLOSURES: Dr. Siegler serves on the Resident and Fellow Section Team for Neurology, and has received research support from NIH (U10 StrokeNet grant, 2017-2018).Jane Ransom is Executive Director of the American Brain Foundation.Dr. Kerber received funding for travel from Elsevier Inc. and the American Academy of Neurology; receives royalties from the publication of the book Clinical Neurophysiology of the Vestibular System, 4th edition; is a consultant for the American Academy of Neurology, University of California San Francisco (including work on a project funded by AstraZeneca), and Best Doctors, Inc.; receives research support from the NIH; received speaker honoraria from American Academy of Neurology and University of California San Francisco and loan repayment award from the NIH; reviewed legal records of Phil Pearsons, MD, JD and National Medical Consultants.Dr. Meurer serves as Decision Editor for the Annals of Emergency Medicine; serves as Methodology Statistics Reviewer for Academic Emergency Medicine; and has received research support from the Massey Foundation for TBI research. Dr. Griggs has served on scientific advisory boards for National Hospital Queen Square, Marathon Pharmaceuticals, Taro Pharmaceuticals, and Sarepta Pharmaceuticals; has served on the data monitoring and safety board for PTC Therapeutics, Inc.; serves on the editorial board for NeuroTherapeutics and Current Treatment Opinions in Neurology; serves as Correspondence Editor for Neurology; receives publishing royalties from Andreoli and Carpenter’s Cecil Essentials of Medicine (Eighth Edition, Elsevier), Cecil Textbook of Medicine (multiple editions, Elsevier), and Evaluation and Treatment of Myopathies (2014, Oxford); has consulted for Marathon, PTC Therapeutics, Sarepta, Taro Pharmaceuticals, Idera Pharmaceuticals, and Strongbridge Pharmaceuticals; receives data royalties and research support from Taro Pharmaceuticals and Marathon Pharmaceuticals; has received research support from NINDS (T32 NS07338, 5U01NS061799, 1R13NS084687), the FDA (R01 FD003923), Parent Project Muscular Dystrophy, Inc., and the Muscular Dystrophy Association; and is the recent past Chair of Executive Committee of the Muscle Study Group.

Delayed Recall - June 2017In this special Delayed Recall episode, Dr. Luca Bartolini speaks with epilepsy experts Dr. Greg Cascino, Dr. Ali Asadi-Pooya, and Dr. Ley Sander. They discuss the results of a recent Practice Current (a section of Neurology® Clinical Practice) survey regarding antiepileptic drug discontinuation, and share their thoughts on best practices with regard to the case studies presented to the survey respondents. This is the first appearance of this interview in the podcast.

1) Early Decompressive Craniectomy for Malignant Cerebral Infarction: Meta-analysis and Clinical Decision Algorithm2) What's Trending: Update on the Resident and Fellows section 3) Topic of the Month: Brain tumors - gliomasThis podcast begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the March 28, 2017 issue of Neurology. In the first segment, Dr. Bryan Eckerle talks with Dr. Bradley Molyneaux and Dr. Christopher Streib about their Neurology® Clinical Practice paper on early decompressive craniectomy for malignant cerebral infarction. Dr. Ted Burns talks with Dr. Roy Strowd about recent updates regarding the Neurology® Resident & Fellows section for our “What's Trending” feature of the week. In the next part of the podcast, Dr. Kait Nevel focuses her interview with Dr. David Schiff on gliomas. Disclosures can be found at Neurology.org. DISCLOSURES:Dr. Molyneaux has received research support from Remedy Pharmaceuticals, Inc.Dr. Streib has served on the Institute for Clinical Systems Improvement (ICSI) Stroke Guidelines Committee (no reimbursement).Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc. Dr. Strowd serves on the editorial board of Neurology (Resident & Fellow section); and has received research support from the Wake Forest School of Medicine Center for Translational Sciences Award, the KL2 Career Development Award, and the American Academy of Neurology.Dr. Schiff has served on the scientific advisory boards of Genetech, Celldex, Orbus, and Vascular Biogenics Oxigene; has received travel funding/speaker honoraria from Merck; serves on the editorial boards of Neurology, Neurosurgery, Neuro-Oncology, and Lancet Neurology; receives publishing royalties from UpToDate, and has been a consultant for Cavion.All other participants report no disclosures.

1) Neurology® Clinical Practice: Incidence of meningeal enhancement on brain MRI secondary to lumbar puncture2) What's Trending: Interview with Robert Gross about his editorial on the trial article format being published this week3) Topic of the month: Neurologic prognosis following cardiac arrestThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jonathan Perk interviews Dr. Sarah Wesley about her Neurology® Clinical Practice paper on the unexplained meningeal enhancement after lumbar puncture. Dr. Ted Burns is interviewing Dr. Robert Gross for our “What's Trending” feature of the week about his editorial on the trial article format being published this week in Neurology. In the next part of the podcast Dr. Andy Schomer interviews Dr. Eelco Wijdicks about the treatment of cardiac arrest and hypothermia management.DISCLOSURES: Dr. Wesley serves on the editorial team for the Neurology® Resident and Fellow Section.Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Dr. Gross receives support for educational endeavors from the University of Rochester Medical Center's Clinical and Translational Science Award from the NIH, since his appointment as Editor-in-Chief in 2009, he has ceased participation in industry-sponsored clinical trials and speakers' bureaus; receives an honorarium from AAN as Editor-in-Chief of Neurology®.Dr. Wijdicks receives royalties from the publication of several books.NO CME WILL BE OFFERED THIS WEEK.

1) Neurology® Clinical Practice: Alice in Wonderland syndrome: a systematic review2) What's Trending: Interview with Clinton Wright about his paper on leisure time physical activity and how it is associated with cognitive decline3) Topic of the month: Frontiers in Neuroscience Plenary Session at the AAN meeting about the implications for neurology and psychiatry in the treatment of cerebellar cognitive affective syndromeThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. David Lapides interviews Dr. Jan Dirk Blom about his Neurology: Clinical Practice paper on the Alice in Wonderland syndrome. Dr. Ted Burns is interviewing Dr. Clinton Wright for our “What's Trending” feature of the week about his paper on leisure time physical activity and how it is associated with cognitive decline. Dr. Alberto Espay interviews Dr. Jeremy Schmahmann about his Frontiers in Neuroscience Plenary Session at the AAN meeting about the implications for neurology and psychiatry in the treatment of cerebellar cognitive affective syndrome.DISCLOSURES: Dr. Blom receives royalties from the publication of the book Hallucinations, Research and Practice and the book A Dictionary of Hallucinations.Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Dr. Wright receives royalties from UpToDate website for two chapters on vascular dementia; receives research support from American Stroke Association-Bugher Foundation Centers of Excellence project and the NIH.Dr. Espay serves as Associate Editor for the Journal of Clinical Movement Disorders; serves as aneditorial board member of Parkinsonism and Related Disorders and The European Neurological Journal; serves on the scientific advisory board for Solvay Pharmaceuticals, Inc. (now Abbvie), Chelsea Therapeutics International, Ltd., Teva Pharmaceutical Industries Ltd., Impax, Merz Pharmaceuticals, Inc., Pfizer Inc, Solstice Neurosciences, Eli Lilly and Company, ACADIA Pharmaceuticals, Inc. and USWorldMeds; is a consultant for Chelsea Therapeutics International, Ltd., Solvay Pharmaceuticals, Inc. (now Abbvie), ACADIA Pharmaceuticals, Inc., Cynapsus and Lundbeck, Inc; receives royalties for publications of books from Lippincott, Williams & Wilkins and Cambridge University Press; serves on the speakers' bureau of UCB, Teva Pharmaceutical Industries Ltd., American Academy of Neurology and Movement Disorders Society; receives research support from the CleveMed/Great Lake Neurotechnologies, Michael J. Fox Foundation and the NIH.Dr. Schmahmann serves as an editorial board member of The Cerebellum and its sister journal, Cerebellum and Ataxias; serves on the scientific advisory board for Ataxion, Inc. and Atlas Ventures; Receives royalties from the publications of the books: The Cerebellum and Cognition: International Review of Neurobiology, MRI Atlas of the Human Cerebellum, Pathways of the Brain, Cerebellar Disorders in Children: Clinics in Development Medicine, and Handbook of the Cerebellum and Cerebellar Disorders; is a consultant for Takeda Pharmaceutical Company Limited; holds stock option in Ataxion, Inc. and Atlas Ventures; receives research support from Birmingham Foundation, MINDlink Foundation, Sidney R. Baer Jr., Foundation, National Ataxia Foundation, Ataxia Telangiectasia Children's Project and the NIH.NO CME WILL BE OFFERED THIS WEEK.

1) Neurology® Clinical Practice: Clinical Exome Sequencing in Neurologic Disease 2) What's Trending: Interview with Natalia del Campo about her paper on relationship of regional brain beta-amyloid to gait speed3) Topic of the month: Neurology Today story about pioglitazone found to be associated with a lower risk of secondary stroke in Non-diabetic patients with insulin resistanceThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Brent Fogel about his Neurology: Clinical Practice paper on clinical exome sequencing in neurologic disease. Dr. Ted Burns is interviewing Dr. Natalia del Campo for our “What's Trending” feature of the week about her paper on relationship of regional brain beta-amyloid to gait speed. Dr. Andy Southerland interviews Dr. Walter Kernan about a Neurology Today story on the topic of pioglitazone found to be associated with a lower risk of secondary stroke in Non-diabetic patients with insulin resistance.DISCLOSURES: Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Dr. Fogel received speaker honoraria from the American Academy of Neurology and American Physician Institute for Advanced Professional Studies; received funding for travel from American Physician Institute for Advanced Professional Studies and National Ataxia Foundation; receives research support from American Physician Institute for Advance Professional Studies, National Ataxia Foundation and the NIH.Dr. Southerland serves as Podcast Deputy Editor for Neurology; receives research support from the American Heart Association-American Stroke Association National Clinical Research Program, American Academy of Neurology, American Board of Psychiatry and Neurology, Health Resources Services Administration and the NIH; has a provisional patent application titled: “Method, system and computer readable medium for improving treatment times for rapid evaluation of acute stroke via mobile telemedicine;” and gave legal expert review.Dr. Kernan academic institution receives research support from Takeda Pharmaceutical Company Limited and the NIH.NO CME WILL BE OFFERED THIS WEEK.

1) Neurology® Clinical Practice article titled: How do you treat anti-NMDA receptor encephalitis?2) e-Pearl topic: Primary lateral sclerosis3) Topic of the month: Pediatric multiple sclerosis This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Lara Marcuse interviews Dr. Luca Bartolini about his Neurology: Clinical Practice paper on how you treat anti-NMDA receptor encephalitis. Dr. Steve O'Donnell is reading our e-Pearl of the week about primary lateral sclerosis. In the next part of the podcast Dr. Nick Brenton interviews Dr. Leigh Charvet about the topic of cognitive, emotional and behavioral outcomes in pediatric multiple sclerosis. DISCLOSURES: Dr. Bartolini serves as Section Editor for Neurology Clinical Practice.Dr. O'Donnell serves on the editorial team for the Neurology Resident and Fellow Section.Dr. Charvet has received research support from Novartis.NO CME WILL BE OFFERED THIS WEEK.

1) Neurology® Clinical Practice: Anti-GAD syndrome with concomitant cerebellar ataxia, stiff-person syndrome, and limbic encephalitis2) What's Trending: Current exciting projects at the AAN3) Topic of the month: Endovascular Stroke Therapy This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Alex Menze interviews Dr. Sara Schaefer about her Neurology: Clinical Practice paper on anti-GAD syndrome with concomitant cerebellar ataxia, stiff-person syndrome, and limbic encephalitis. Dr. Ted Burns is interviewing Cathy Rydell for our “What's Trending” feature of the week about current exciting projects happening at the AAN. In the next part of the podcast Dr. Prachi Mehndiratta interviews Dr. Max Wintermark about the topic of imaging modalities used as selection criteria in endovascular stroke therapy. DISCLOSURES: Dr. Ted Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with UCB, CSL Behring, Walgreens and Alexion Pharmaceuticals, Inc.Catherine M. Rydell is Executive Director & Chief Executive Officer, American Academy of Neurology.Dr. Wintermark serves as an editorial board member of American Journal of Neuroradiology and American Journal of Roentgenology; serves on the scientific advisory board for the GE-NFL board.NO CME WILL BE OFFERED THIS WEEK.

1) Neurology® Clinical Practice: Medical Marijuana: Between a plant and a hard place and 2) Topic of the month: Updates in tele-neurology. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matthew Wong interviews Dr. David Gloss about his Neurology Clinical Practice paper on medical marijuana: Between a plant and a hard place. Dr. Sarah Wesley is reading our e-Pearl of the week about arterial retinal ischemic disease. In the next part of the podcast Dr. Andy Southerland interviews Dr. Bert Vargas about the topic of teleconcussion. The participants had nothing to disclose except Drs. Gloss, Wesley, Southerland and Vargas.Dr. Gloss serves as an evidence-based medicine consultant for the American Academy of Neurology; serves as an LOE associate editor for Neurology® and receives royalties from the publicationof the book Neurology for the Specialty Boards.Dr. Wesley serves on the editorial team for the Neurology® Resident and Fellow Section.Dr. Southerland serves as Podcast Deputy Editor for Neurology®; serves as Clinical Research Advisor for Totier Technologies, Inc.Dr. Vargas serves on the scientific advisory boards Allergan, Inc and Zogenix, Inc.; receives honoraria for travel from the American Headache Society.NO CME WILL BE OFFERED THIS WEEK.